Dyslipidemia in Children Treated with a BRAF Inhibitor for Low-Grade Gliomas: A New Side Effect?

SIMPLE SUMMARY: The use of targeted therapies is revolutionizing the prognosis of many cancers; however, there is still limited knowledge of their side effects. Dyslipidemia is often present in cancer patients due to mechanisms that are directly or indirectly related to cancer or therapies. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Crocco, Marco, Verrico, Antonio, Milanaccio, Claudia, Piccolo, Gianluca, De Marco, Patrizia, Gaggero, Gabriele, Iurilli, Valentina, Di Profio, Sonia, Malerba, Federica, Panciroli, Marta, Giordano, Paolo, Calevo, Maria Grazia, Casalini, Emilio, Di Iorgi, Natascia, Garrè, Maria Luisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179293/
https://www.ncbi.nlm.nih.gov/pubmed/35681673
http://dx.doi.org/10.3390/cancers14112693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179293/
https://www.ncbi.nlm.nih.gov/pubmed/35681673
http://dx.doi.org/10.3390/cancers14112693

Ejemplares similares